当前位置:首页 - 行情中心 - 重药控股(000950) - 财务分析 - 现金流量表

重药控股

(000950)

  

流通市值:87.52亿  总市值:87.52亿
流通股本:17.13亿   总股本:17.13亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金65,712,198,028.343,089,889,542.1720,196,351,385.4292,156,419,477.04
  收到的税费返还---0
  收到其他与经营活动有关的现金1,135,454,306.9704,408,323.77413,641,514.482,439,535,741.11
  经营活动现金流入小计66,847,652,335.243,794,297,865.9420,609,992,899.994,595,955,218.15
  购买商品、接受劳务支付的现金64,656,747,160.1343,435,642,906.1121,958,766,531.9186,075,400,363.66
  支付给职工以及为职工支付的现金1,428,322,584.46971,488,272.5551,084,585.331,884,333,443.88
  支付的各项税费1,266,765,049.94983,709,382.13480,353,448.31,549,825,517.88
  支付其他与经营活动有关的现金2,872,764,650.362,012,886,635.67935,963,247.784,331,725,803.35
  经营活动现金流出小计70,224,599,444.8947,403,727,196.4123,926,167,813.3293,841,285,128.77
  经营活动产生的现金流量净额-3,376,947,109.69-3,609,429,330.47-3,316,174,913.42754,670,089.38
二、投资活动产生的现金流量:
  收回投资收到的现金0--339,416,960.53
  取得投资收益收到的现金148,279,866.04147,338,119.1-119,038,363.74
  处置固定资产、无形资产和其他长期资产收回的现金净额408,087.86189,486.8782,3081,011,324
  处置子公司及其他营业单位收到的现金净额5,908,348.94497,756.49-399,607.57
  收到的其他与投资活动有关的现金31,214,900.3115,506,497.5513,652,243.8858,449,051.41
  投资活动现金流入小计185,811,203.15163,531,860.0113,734,551.88518,315,307.25
  购建固定资产、无形资产和其他长期资产支付的现金234,762,451.01182,757,927.7499,833,118.4299,539,838.25
  投资支付的现金3,570,000--0
  质押贷款净增加额---0
  取得子公司及其他营业单位支付的现金6,604,785.966,604,785.96-25,203,406.42
  支付其他与投资活动有关的现金11,318,679.580-29,823,589.59
  投资活动现金流出小计256,255,916.55189,362,713.799,833,118.4354,566,834.26
  投资活动产生的现金流量净额-70,444,713.4-25,830,853.69-86,098,566.52163,748,472.99
三、筹资活动产生的现金流量:
  吸收投资收到的现金00-238,713,461.41
  其中:子公司吸收少数股东投资收到的现金00-238,713,461.41
  取得借款收到的现金19,107,029,028.8213,616,166,690.976,027,596,568.8824,752,970,472.55
  收到其他与筹资活动有关的现金498,025,351.23263,182,340.24200,276,681.06392,200,549.65
  筹资活动现金流入小计19,605,054,380.0513,879,349,031.216,227,873,249.9425,383,884,483.61
  偿还债务支付的现金16,103,395,918.3310,435,448,394.673,663,771,379.2124,114,209,320.98
  分配股利、利润或偿付利息支付的现金779,518,891.6487,499,540.63218,372,485.891,170,710,564.26
  其中:子公司支付给少数股东的股利、利润221,086,619.7674,401,741.927,188,840.32297,144,355.83
  支付其他与筹资活动有关的现金617,267,855.35445,096,552.33169,185,859.851,053,399,419.07
  筹资活动现金流出小计17,500,182,665.2811,368,044,487.634,051,329,724.9526,338,319,304.31
  筹资活动产生的现金流量净额2,104,871,714.772,511,304,543.582,176,543,524.99-954,434,820.7
五、现金及现金等价物净增加额-1,342,520,108.32-1,123,955,640.58-1,225,729,954.95-36,016,258.33
  加:期初现金及现金等价物余额4,750,966,315.914,750,966,315.914,750,966,315.914,786,982,574.24
  期末现金及现金等价物余额3,408,446,207.593,627,010,675.333,525,236,360.964,750,966,315.91
补充资料:
  净利润-312,530,169.22-521,328,438.97
  资产减值准备-5,223,536-909,318,679.07
  固定资产和投资性房地产折旧-111,259,818.05-239,347,525.35
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-111,259,818.05-239,347,525.35
  无形资产摊销-16,918,938.74-36,333,178.67
  长期待摊费用摊销-26,669,738.93-58,564,157.16
  处置固定资产、无形资产和其他长期资产的损失--3,883,377.54--4,629,873.82
  固定资产报废损失----189,424.35
  公允价值变动损失-43,645.49-3,068,104.51
  财务费用-323,158,126.58-758,261,522.73
  投资损失--138,529,695.28--415,481,340.47
  递延所得税--35,000,893.74--275,511,823.92
  其中:递延所得税资产减少--38,790,793.86--308,971,250.41
    递延所得税负债增加-3,789,900.12-33,459,426.49
  存货的减少-67,616,892.79--149,151,116.18
  经营性应收项目的减少--3,386,957,165.25--2,800,383,331.27
  经营性应付项目的增加--1,683,659,481.69-1,673,291,496.93
  其他-694,366,822.78--
  现金的期末余额-3,627,010,675.33-4,750,966,315.91
  减:现金的期初余额-4,750,966,315.91-4,786,982,574.24
  现金及现金等价物的净增加额--1,123,955,640.58--36,016,258.33
公告日期2026-10-242026-08-262026-04-242026-04-24
审计意见(境内)标准无保留意见
TOP↑